CrestarBio is dedicated to providing high quality biomaterials and human tissues for research purposes. Our goal is to partner with our clients � to assist our clients in developing a deeper understanding of human disease processes and their underlying mechanisms.
We provide biospecimens and support services necessary for advancing genomics, proteomics, and biomarker research.
CrestarBio helps accelerate drug target discovery validation, leading to new and improved therapeutics. We facilitate scientific discovery from the lab into clinical practice.
We provide a wide range of specimen types, including matched sets of normal and diseased human tissues, FFPE blocks, blood, serum, and plasma with associated and customized patient data focusing primarily on oncology. Samples in other therapeutic areas such as cardiovascular disease, central nervous system disorders, and other disease such as diabetes and hypertension are also available.
CrestarBio provides tissue and tissue derivatives that are high quality, cost effective, and procured in compliance with current and anticipated regulations throughout our global repository. Our company obtains its clinical specimens under strict IRB approved protocols with informed consent and uncompromising adherence to issues of patient safety, anonymity, and confidentiality. Informed consent is required from all donors irrespective of the host country regulatory requirements. Compliance with FDA regulations and adherence to international ethical standards such as ICH-GCP is paramount to our mission. Independent IRB and local ethics committee approvals are maintained at each clinical site.
9C First Comercial
Lane Zamzama D.H.A.
Phase-5 Karachi 75600,